Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

JetPeel-assisted minoxidil improves hair density and thickness more than minoxidil alone.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Men with severe hair loss may have poorer sperm quality.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Where a rhesus macaque used to live can affect its chances of getting alopecia later in life, and females are more likely to be affected than males.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Higher doses of cranial irradiation are linked to permanent hair loss.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.